|
JRC Publications Repository >
Browsing by Author APOSTOLIDIS Christos
Showing results 78 to 97 of 129
| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type | | 2012 | Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostate | RIZVI S.m.a.; ALLEN B.j.; LEE C.s.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; CLARKE R.a. | Articles in Journals |
| 1996 | Oxo-Bridged Bimetallic Organouranium Complexes. The Crystal Structure of nu-Oxo-Bis[Tris(Cyclopentadienyl)Uranium] | SPIRLET M.r.; REBIZANT Jean; APOSTOLIDIS Christos; DORNBERGER Ernst; POWIETZKA B. | Articles in Journals |
| 2007 | Pharmacokinetics and toxicity of 213Bi-labeled PAI2 in Preclinical Targeted Alpha Therapy for Cancer | SONG E.; ABBAS RIZVI S. M.; QU C. F.; RAJA C.; BRECHBIEL M. W.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J. | Articles in Journals |
| 2005 | Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer | QU C.f.; SONG E.; LI Y.; RIZVI S.m.a.; RAJA C.; ROSS R; APOSTOLIDIS CHRISTOS; ALLEN Barry J.; MORGENSTERN ALFRED | Articles in Journals |
| 2006 | Preclinical Studies of Bismuth-213 Labeled Plasminogen Activator Inhibitor Type 2 (PAI2) in a Prostate Cancer Nude Mouse Xenograft Model | RIZVI S.m.a.; LI Y.; SONG E.; QU C.f.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B.j. | Articles in Journals |
| 2008 | Preparation and Testing of Bevacizumab Radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206 | RIZVI S.; SONG E.; RAJA C.; BERETOV J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; RUSSELL P. J.; KEARSLEY J.; ABBAS Kamel; ALLEN B. J. | Articles in Journals |
| 2008 | Production of 230U/226Th for Targeted Alpha Therapy via Proton Irradiation of 231Pa | MORGENSTERN Alfred; LEBEDA O.; STURSA J.; BRUCHERTSEIFER Frank; CAPOTE R.; MCGINLEY John; RASMUSSEN Gert; SIN M.; ZIELINSKA B.; APOSTOLIDIS Christos | Articles in Journals |
| 1998 | Production of Ac-225 and Application of the Bi-213 Daughter in Cancer Therapy. | KOCH Lothar; APOSTOLIDIS Christos; JANSSENS Willem; VAN GEEL Jacobus; MOLINET Roger | Contributions to Conferences |
| 2005 | Production of Ac-225 from Th-229 for Targeted Alpha Therapy | APOSTOLIDIS CHRISTOS; MOLINET Roger; MORGENSTERN ALFRED | Articles in Journals |
| 2008 | Production of Alpha Emitters for Targeted Alpha Therapy | MORGENSTERN Alfred; ABBAS Kamel; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos | Articles in Journals |
| 2008 | Production of Alpha Emitting Radionuclides for Nuclear Medicine | MORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank | Articles in books |
| 2001 | Production of Carrier Free Actinium-225/Bismuth-212 from Thorium-229 for alpha-Immunitherapy. | APOSTOLIDIS Christos; BETTI Maria; CARLOS-MARQUEZ R.; JANSSENS Willem; MOLINET Roger; NIKULA T.; QUADI Ali | Contributions to Conferences |
| 2009 | Radioimmunotherapy of Breast Cancer Metastases with Alpha-Particle-emitter 225Ac: Comparing Efficacy with 213Bi, 90Y | SONG Hong; HOBBS Robert F.; VAJRAVELU Ravy; HUSO David L.; ESAIAS Caroline; APOSTOLIDIS Christos; MORGENSTERN Alfred; SGOUROS George | Articles in Journals |
| 2009 | Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAb | PFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2001 | Radiopeptide Therapy with Cholecystokinin(CCK)-B/Gastrin Receptor Ligands Labeled with Auger/Conversion Electron-versus alpha- or Conventional beta Emitters. | BEHR T.m.; BEHE M.; ANGERSTEIN C.; STABIN M.g.; APOSTOLIDIS Christos; MOLINET Roger; KOCH Lothar; ROESCH F.; BECKER W. | Contributions to Conferences |
| 2000 | Radiopeptide Therapy with Cholecystokinin-B/Gastrin Receptor Ligands: Dose-Limiting Toxicity and Therapeutic Efficacy of Auger / Conversion Electron (111-In, 140-Nd) vs alpha(213-Bi) or Conventional beta(90-Y, 153-Sm) Emitters. | BEHR T.m.; BEBE M.; STABIN M.g.; ANGERSTEIN C.; MACH R.; HAGEMANN L.; APOSTOLIDIS Christos; MOLINET Roger; KOCH Lothar; ROESCH F., et al | Contributions to Conferences |
| 2012 | Reduction of Pu(VI) by Fe | CARBOL Paul; WEGEN Detlef; WISS Thierry; JANSSEN ARNE; NICHOLL Adrian; CREMER Bert; MALMBECK Rikard; VAN WINCKEL Stefaan; APOSTOLIDIS Christos; ALVAREZ SARANDES LAVANDERA Rafael, et al | Contributions to Conferences |
| 2001 | Separation of 248Cm from a 252Cf Neutron Source for Production of Cm Targets. | MALMBECK R.; APOSTOLIDIS Christos; CARLOS R.; GLATZ Jean paul; MOLINET Roger; MORGENSTERN A.; NICHOLL Adrian felim; PAGLIOSA G.; ROEMER K.; SCHAEDEL M., et al | Articles in Journals |
| 2004 | Sequential Therapy with Cytarabine and Bismuth-213 (213BI)-Labeled-HuM195(Anit-CD33) for Acute Myeloid Leukemia (AML). | MULFORD D.a.; PANDIT-TASKAR N.; MC DEVITT M.r.; FINN R.d.; APOSTOLIDIS Christos; MORGENSTERN A.; DIVGI C.r.; LARSON S.m.; SCHEINBERG D.a.; JURCIC J.g. | Contributions to Conferences |
| 2002 | Single-Column Extraction Chromatographic Separation of U, Np, Pu and Am. | MORGENSTERN A.; APOSTOLIDIS Christos; CARLOS-MARQUEZ R.; MAYER Klaus; MOLINET Roger | Articles in Journals |
Showing results 78 to 97 of 129
|
